This inventor holds 2 USPTO granted patents. Top assignee: Scinnohub Pharmaceutical Co., Ltd. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Jialing Xian: Innovator in Hemostasis Research
Introduction
Jialing Xian is a prominent inventor based in Chengdu, China. He has made significant contributions to the field of pharmaceutical sciences, particularly in the area of hemostasis. His innovative work has led to the development of a unique compound that has potential applications in medical treatments.
Latest Patents
Jialing Xian holds a patent for a plasmin inhibitor, which includes a preparation method and its applications. This compound, described by the formula (I), is capable of inhibiting plasmin activity, thereby delaying fibrinolysis. It exhibits coagulation and hemostatic activity, and includes pharmaceutically acceptable salts, hydrates, isomers, prodrugs, and mixtures thereof. The specific components X and R are defined in the detailed description of the patent. He has 1 patent to his name.
Career Highlights
Jialing Xian is currently associated with Scinnohub Pharmaceutical Co., Ltd., where he continues to advance his research in the pharmaceutical field. His work is pivotal in developing new therapeutic strategies for managing bleeding disorders.
Collaborations
Jialing collaborates with notable colleagues, including Anle Yang and Sen Ji, who contribute to his research endeavors. Their combined expertise enhances the innovative potential of their projects.
Conclusion
Jialing Xian's contributions to the field of hemostasis through his innovative patent demonstrate his commitment to advancing medical science. His work has the potential to significantly impact therapeutic approaches in the future.